A Metabolomic Approach to Predict Breast Cancer Behavior and Chemotherapy Response
AbstractAlthough the classification of breast carcinomas into molecular or immunohistochemical subtypes has contributed to a better categorization of women into different therapeutic regimens, breast cancer nevertheless still progresses or recurs in a remarkable number of patients. Identifying women who would benefit from chemotherapy could potentially increase treatment effectiveness, which has important implications for long-term survival. Metabolomic analyses of fluids and tissues from cancer patients improve our knowledge of the reprogramming of metabolic pathways involved in resistance to chemotherapy. This review evaluates how recent metabolomic approaches have contributed to understanding the relationship between breast cancer and the acquisition of resistance. We focus on the advantages and challenges of cancer treatment and the use of new strategies in clinical care, which helps us comprehend drug resistance and predict responses to treatment. View Full-Text
Share & Cite This Article
Cardoso, M.R.; Santos, J.C.; Ribeiro, M.L.; Talarico, M.C.R.; Viana, L.R.; Derchain, S.F.M. A Metabolomic Approach to Predict Breast Cancer Behavior and Chemotherapy Response. Int. J. Mol. Sci. 2018, 19, 617.
Cardoso MR, Santos JC, Ribeiro ML, Talarico MCR, Viana LR, Derchain SFM. A Metabolomic Approach to Predict Breast Cancer Behavior and Chemotherapy Response. International Journal of Molecular Sciences. 2018; 19(2):617.Chicago/Turabian Style
Cardoso, Marcella R.; Santos, Juliana C.; Ribeiro, Marcelo L.; Talarico, Maria C.R.; Viana, Lais R.; Derchain, Sophie F.M. 2018. "A Metabolomic Approach to Predict Breast Cancer Behavior and Chemotherapy Response." Int. J. Mol. Sci. 19, no. 2: 617.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.